Veeva Systems (NYSE:VEEV – Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 7.320-7.320 for the period, compared to the consensus EPS estimate of 6.970. The company issued revenue guidance of $3.0 billion-$3.1 billion, compared to the consensus revenue estimate of $3.1 billion. Veeva Systems also updated its Q1 2026 guidance to 1.740-1.750 EPS.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on VEEV shares. Truist Financial decreased their target price on Veeva Systems from $261.00 to $210.00 and set a “hold” rating for the company in a research report on Monday, January 13th. Needham & Company LLC restated a “buy” rating and issued a $270.00 price target on shares of Veeva Systems in a report on Friday, January 17th. Royal Bank of Canada lifted their price target on shares of Veeva Systems from $275.00 to $285.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. StockNews.com upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating in a report on Monday, February 17th. Finally, Stephens assumed coverage on Veeva Systems in a report on Friday, December 20th. They set an “overweight” rating and a $280.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $254.48.
Read Our Latest Analysis on Veeva Systems
Veeva Systems Stock Up 0.9 %
Veeva Systems (NYSE:VEEV – Get Free Report) last released its earnings results on Wednesday, March 5th. The technology company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.58 by ($0.39). Veeva Systems had a return on equity of 13.56% and a net margin of 25.07%. Analysts anticipate that Veeva Systems will post 4.35 EPS for the current year.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Articles
- Five stocks we like better than Veeva Systems
- How to buy stock: A step-by-step guide for beginnersÂ
- Corporate Crawl: Where Business Trips Turn Into Party Nights?
- Top Biotech Stocks: Exploring Innovation Opportunities
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Differences Between Momentum Investing and Long Term Investing
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.